Insiders Updates An Analysis of Ligand Pharmaceuticals, Inc (LGND)’s Potential Price Growth Ligand Pharmaceuticals, Inc’s recently made public that its Director KOZARICH JOHN W unloaded Company’s shares for reported $61586.0 on Aug
Analysts Viewpoint Understanding the Risks of Investing in Ligand Pharmaceuticals, Inc (LGND) Ligand Pharmaceuticals, Inc’s filing revealed that its Director KOZARICH JOHN W unloaded Company’s shares for reported $0.12 million on Jul